Cargando…

The POSEIDON stratification - moving from poor ovarian response to low prognosis

Poor ovarian response remains one of the most challenging tasks for an IVF clinician. In this review, we aim to highlight the ongoing research for optimizing the prognosis in poor ovarian response patients. The newly introduced POSEIDON criteria argue that the first step is to move from a poor respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roque, Matheus, Haahr, Thor, Esteves, Sandro C., Humaidan, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brazilian Society of Assisted Reproduction 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083858/ https://www.ncbi.nlm.nih.gov/pubmed/33565297 http://dx.doi.org/10.5935/1518-0557.20200100

Ejemplares similares

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
por: Esteves, Sandro C., et al.
Publicado: (2018)

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
por: Humaidan, Peter, et al.
Publicado: (2016)

Individualized controlled ovarian stimulation in expected poor-responders: an update
por: Haahr, Thor, et al.
Publicado: (2018)

GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis
por: Haahr, Thor, et al.
Publicado: (2017)

Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations
por: Abu-Musa, Antoine, et al.
Publicado: (2020)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
por: Esteves, Sandro C., et al.
Publicado: (2019)

Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria
por: Lee, Hyun Joo, et al.
Publicado: (2022)

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019)

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
por: Esteves, Sandro C., et al.
Publicado: (2021)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study
por: Fuentes, Ariel, et al.
Publicado: (2019)

Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Li, Yuan, et al.
Publicado: (2019)

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021)

GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023)

Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients
por: Esteves, Sandro C, et al.
Publicado: (2021)

Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
por: Esteves, Sandro C., et al.
Publicado: (2021)

Low biomass microbiota in the upper genital tract of reproductive age women: fact or fiction?
por: Haahr, Thor, et al.
Publicado: (2020)

Protein supplementation intake for bodybuilding and resistance training may impact sperm quality of subfertile men undergoing fertility treatment: a pilot study
por: Ketheeswaran, Shathmigha, et al.
Publicado: (2019)

Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria
por: Farimani, Marzieh, et al.
Publicado: (2021)

Comparative Effectiveness of Mild or Conventional GnRH-Antagonist Protocols for Ovarian Stimulation in Poor Responders (Poseidon Group 4)
por: Le, Hoang, et al.
Publicado: (2020)

Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria
por: Farimani, Marzieh, et al.
Publicado: (2021)

The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot study
por: Humaidan, Peter, et al.
Publicado: (2021)

Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials
por: Dosouto, Carlos, et al.
Publicado: (2019)

Management Strategies for POSEIDON's Group 1
por: Polyzos, Nikolaos P., et al.
Publicado: (2019)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Comparison of Cumulative Live Birth Rates between Flexible and Conventional Progestin-Primed Ovarian Stimulation Protocol in Poor Ovarian Response Patients According to POSEIDON Criteria: A Cohort Study
por: Chen, Ying, et al.
Publicado: (2023)

Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles
por: Bansiwal, Reeta, et al.
Publicado: (2023)

Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the POSEIDON Criteria
por: Li, Fei, et al.
Publicado: (2021)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

POSEIDON: The secrets of the Trident Node monitoring tool
por: Kuffo Rivero, Leonardo Xavier
Publicado: (2018)

An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria
por: Levi-Setti, Paolo Emanuele, et al.
Publicado: (2019)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Bühler, Klaus F.
Publicado: (2020)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Fischer, Robert, et al.
Publicado: (2020)

Effectiveness of oestrogen pretreatment in patients with expected poor ovarian response (POSEIDON groups 3 and 4) undergoing GnRH antagonist protocol: study protocol for a randomised controlled trial
por: Han, Qiao-Song, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33jsaaol78tpbfutmhp4im6i89